IBDEI15C ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18612,0)
 ;;=I48.0^^64^833^47
 ;;^UTILITY(U,$J,358.3,18612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18612,1,3,0)
 ;;=3^Atrial Fibrillation,Paroxysmal
 ;;^UTILITY(U,$J,358.3,18612,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,18612,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,18613,0)
 ;;=I49.9^^64^833^50
 ;;^UTILITY(U,$J,358.3,18613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18613,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,18613,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,18613,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,18614,0)
 ;;=I42.9^^64^833^51
 ;;^UTILITY(U,$J,358.3,18614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18614,1,3,0)
 ;;=3^Cardiomyopathy,Unspec
 ;;^UTILITY(U,$J,358.3,18614,1,4,0)
 ;;=4^I42.9
 ;;^UTILITY(U,$J,358.3,18614,2)
 ;;=^5007200
 ;;^UTILITY(U,$J,358.3,18615,0)
 ;;=I50.42^^64^833^53
 ;;^UTILITY(U,$J,358.3,18615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18615,1,3,0)
 ;;=3^Chr Combined Systolic & Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,18615,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,18615,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,18616,0)
 ;;=I50.32^^64^833^54
 ;;^UTILITY(U,$J,358.3,18616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18616,1,3,0)
 ;;=3^Chr Diastolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,18616,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,18616,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,18617,0)
 ;;=I27.82^^64^833^55
 ;;^UTILITY(U,$J,358.3,18617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18617,1,3,0)
 ;;=3^Chr Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,18617,1,4,0)
 ;;=4^I27.82
 ;;^UTILITY(U,$J,358.3,18617,2)
 ;;=^338238
 ;;^UTILITY(U,$J,358.3,18618,0)
 ;;=I50.22^^64^833^57
 ;;^UTILITY(U,$J,358.3,18618,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18618,1,3,0)
 ;;=3^Chr Systolic Congestive Hrt Failure
 ;;^UTILITY(U,$J,358.3,18618,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,18618,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,18619,0)
 ;;=I42.0^^64^833^60
 ;;^UTILITY(U,$J,358.3,18619,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18619,1,3,0)
 ;;=3^Dilated Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,18619,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,18619,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,18620,0)
 ;;=I10.^^64^833^62
 ;;^UTILITY(U,$J,358.3,18620,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18620,1,3,0)
 ;;=3^Essential Hypertension
 ;;^UTILITY(U,$J,358.3,18620,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,18620,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,18621,0)
 ;;=I50.9^^64^833^67
 ;;^UTILITY(U,$J,358.3,18621,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18621,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,18621,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,18621,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,18622,0)
 ;;=I35.1^^64^833^76
 ;;^UTILITY(U,$J,358.3,18622,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18622,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,18622,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,18622,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,18623,0)
 ;;=I35.0^^64^833^77
 ;;^UTILITY(U,$J,358.3,18623,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18623,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,18623,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,18623,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,18624,0)
 ;;=I35.2^^64^833^78
 ;;^UTILITY(U,$J,358.3,18624,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18624,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
